Dr. Agarwal's Health Care Limited (BOM:544350)

Market Cap	153.44B +36.5%
Revenue (ttm)	20.80B +21.6%
Net Income	1.33B +59.6%
EPS	4.18 +50.4%
Shares Out	n/a
PE Ratio	115.20
Forward PE	82.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,716
Open	484.85
Previous Close	480.10
Day's Range	478.00 - 488.50
52-Week Range	327.40 - 567.80
Beta	n/a
Analysts	Buy
Price Target	545.00 (+12.65%)
Earnings Date	May 21, 2026

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr...

• Industry: Health Services
• Founded: 2010
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544350

Financial Performance

In fiscal year 2026, Dr. Agarwal's Health Care's revenue was 20.80 billion, an increase of 21.57% compared to the previous year's 17.11 billion. Earnings were 1.33 billion, an increase of 59.59%.